文献速递头颈部肿瘤放疗放疗物理与技术

揭示碳离子用于头颈部肿瘤再照射临床潜力的方法:前瞻性随机CARE试验中的剂量学比较与局部失败模式分析

Ways to unravel the clinical potential of carbon ions for head and neck cancer reirradiation: dosimetric comparison and local failure pattern analysis as part of the prospective randomized CARE trial.
PubMed 文献 · Radiat Oncol · 2022-07-08

该研究基于前瞻性随机CARE试验中16例头颈部肿瘤再照射患者,比较碳离子放疗(CIRT)与容积旋转调强放疗(VMAT)的剂量体积参数和局部失败模式。结果显示CIRT在靶区剂量增加的情况下,危及器官剂量显著降低(平均剂量-8.7%),脑干最大剂量降低20.7%,视交叉最大剂量降低13.0%。局部失败最常见为E型(野外型,50%),其次为B型(周边型,33%)和A型(中心型,17%)。

要点

  • CIRT较VMAT在头颈再照射中显著降低危及器官剂量,脑干Dmax降低20.7%,视交叉Dmax降低13.0%。
  • CIRT靶区剂量增加,但所有患者危及器官平均剂量降低8.7%。
  • 局部失败以E型(野外型)最常见(50%),其次B型(周边型,33%)和A型(中心型,17%)。

核心结论

  • CIRT在所有头颈部肿瘤再照射场景中较VMAT显著改善关键危及器官保护,尽管处方剂量增加。
  • 局部失败模式分析揭示了CIRT进一步潜在的临床获益以及关于图像引导和生物剂量优化的潜在陷阱。

研究设计与样本

  • 研究基于前瞻性随机CARE试验,纳入16例头颈部肿瘤再照射患者,比较CIRT与VMAT的剂量体积参数和局部失败模式。

主要发现

  • CIRT较VMAT在所有患者中显著降低危及器官剂量,平均剂量降低8.7%。
  • 剂量体积获益在脑干最明显(Dmax降低20.7%),其次为视交叉(Dmax降低13.0%)。
  • 局部失败最常见为E型(野外型,50%),其次为B型(周边型,33%)和A型(中心型,17%)。
  • 一例CIRT后A型生物和/或剂量学失败患者,mMKM剂量重新计算显示靶区覆盖降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carbon ion radiotherapy (CIRT) yields biophysical advantages compared to photons but randomized studies for the reirradiation setting are pending. The aim of the current project was to evaluate potential clinical benefits and drawbacks of CIRT compared to volumetric modulated arc therapy (VMAT) in recurrent head and neck cancer. METHODS: Dose-volume parameters and local failure patterns of CIRT compared to VMAT were evaluate in 16 patients from the randomized CARE trial on head and neck cancer reirradiation. RESULTS: Despite an increased target dose, CIRT resulted in significantly reduced organ at risk (OAR) dose across all patients (- 8.7% Dmean). The dose-volume benefits were most pronounced in the brainstem (- 20.7% Dmax) and the optic chiasma (- 13.0% Dmax). The most frequent local failure was type E (extraneous; 50%), followed type B (peripheral; 33%) and type A (central; 17%). In one patient with type A biological and/or dosimetric failure after CIRT, mMKM dose recalculation revealed reduced target coverage. CONCLUSIONS: CIRT resulted in highly improved critical OAR sparing compared to VMAT across all head and neck cancer reirradiation scenarios despite an increased prescription dose. Local failure pattern analysis revealed further potential CIRT specific clinical benefits and potential pitfalls with regard to image-guidance and biological dose-optimization.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Held T, Tessonnier T, Franke H, et al. Ways to unravel the clinical potential of carbon ions for head and neck cancer reirradiation: dosimetric comparison and local failure pattern analysis as part of the prospective randomized CARE trial. Radiat Oncol. 2022. PMID: 35804448. doi:10.1186/s13014-022-02093-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。